Speaker illustration

Professor Eduard Malev

Almazov National Medical Research Centre, Saint Petersburg (Russian Federation)

Circulating transforming growth factor-beta1 and progression of the mitral valve prolapse: fifteen-year follow-up

Event: ESC Congress 2021 - The Digital Experience

Topic: Mitral Valve Prolapse

Session: A deep dive into mitral regurgitation

Thumbnail

Angiotensin II receptor blockers in modulation of transforming growth factor-beta effects on mitral valve myxomatous degeneration

Event: ESC Congress 2021 - The Digital Experience

Topic: Pathophysiology and Mechanisms

Session: Valvular heart disease and infective endocarditis e-posters

Thumbnail

Midventricular obstruction and left ventricular remodeling after transcatheter aortic valve implantation

Event: EACVI - Best of Imaging 2020

Topic: Valvular Heart Disease

Session: ePoster session

Thumbnail

Risk factors of persistent ventricular arrhythmias after mitral valve repair in Barlow disease patients: six-year follow-up

Event: EACVI - Best of Imaging 2020

Topic: Valvular Heart Disease

Session: ePoster session

Thumbnail

Thoracic aorta and circulating transforming growth factor-b in marfan syndrome and marfanoid habitus

Event: EuroEcho 2019

Topic: Imaging of Aortic Disease

Session: Imaging: Aortic Disease

Thumbnail

Effects of mitral valve repair on left ventricular remodeling and ventricular arrhythmia in mitral valve prolapse patients: five-year follow-up

Event: EuroEcho 2019

Topic: Valvular Heart Disease

Session: What is new in mitral valve intervention

Thumbnail

Transforming growth factor-beta and arrhythmias in mitral valve prolapse patients

Event: ESC Congress 2019

Topic: Valvular Heart Disease

Session: Heart values

Thumbnail

Effect of renin-angiotensin system blockade in prevention of thoracic aortic aneurysm progression

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Aortic disease: clinical and treatment

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb